Results 21 to 30 of about 29,100 (168)

Risperidone-induced maculopapular rashes in a child

Annals of Indian Psychiatry, 2023
We report the case and the literature focusing on dermatological problems as a possible side effect of risperidone. A 10-year-old boy with attention deficit hyperactivity disorder, who was maintaining well on atomoxetine, developed rashes on addition of ...
Enub Ali, Ankur Sachdeva, Shanta Passi
doaj   +1 more source

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels

Neuropsychopharmacology Reports, 2021
Aim Several reports have shown that risperidone increases prolactin concentrations, while aripiprazole decreases prolactin concentrations. The frequency of abnormal prolactin concentrations in patients with schizophrenia receiving these drugs is still ...
Minami Tasaki, Norio Yasui‐Furukori, Saaya Yokoyama, Masataka Shinozaki, Norio Sugawara, Kazutaka Shimoda   +5 more
doaj   +1 more source

Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study

Annals of General Psychiatry, 2009
Background A reporting association of risperidone with pituitary tumors has been observed. Because such tumors are highly prevalent, there may be other reasons why they were revealed in association with risperidone treatment.
Wu Jasmanda, Mahmoud Ramy, Pandina Gahan, Gianfrancesco Frank D, Wang Ruey H   +4 more
doaj   +1 more source

Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis

BMC Psychiatry, 2011
Background To compare the efficacy and tolerability of paliperidone extended-release (ER) with risperidone immediate-release using propensity score methodology.
Schooler Nina, Lindenmayer Jean-Pierre, Bossie Cynthia A, Turkoz Ibrahim, Canuso Carla M   +4 more
doaj   +1 more source

The role of harms and burdens in clinical practice guidelines: Lessons learned from the American Psychological Association's guideline development

Clinical Psychology: Science and Practice, EarlyView., 2020
Abstract Growing evidence supports the efficacy of various psychosocial interventions yet provides very little information about the potential harms and burdens of treatment. Lacking such information makes it difficult to make truly informed decisions about treatment options.
Raquel W. Halfond, Caroline Vaile Wright, Lynn F. Bufka   +2 more
wiley   +1 more source

Factors influencing blood prolactin levels in patients with schizophrenia under risperidone treatment

Taiwanese Journal of Psychiatry, 2023
Objectives: Risperidone, a dopamine and serotonin antagonist or a second-generation (atypical) antipsychotic drug, is commonly prescribed for various psychiatric disorders, including schizophrenia, bipolar disorder, and autism spectrum disorders.
Mong-Liang Lu, Yi-Hang Chiu, Kah Kheng Goh   +2 more
doaj   +1 more source

A case of diverse psychiatric and functional impairments following immune checkpoint inhibitor therapy. [PDF]

PCN Rep
Abstract Background Immune checkpoint inhibitors (ICIs) can cause a range of immune‐related adverse events (irAEs), including rare neuropsychiatric complications. However, these events often present with diverse and non‐specific symptoms, making diagnosis difficult.
Ikegami T, Sadahiro R, Yamaguchi J, Nishikawa E, Wada S, Terada T, Nakahara R, Matsuoka H.   +7 more
europepmc   +2 more sources

Efficacy and safety of brand-risperidone versus similar-risperidone in elderly patients with neuropsychiatric disorders: A retrospective study

Dementia & Neuropsychologia
To compare the efficacy and tolerability of brand-risperidone against similar-risperidone in elderly outpatients. Method: The medical files of 16 elderly outpatients from the IPq-HCFMUSP treated with two formulations of risperidone (brand and similar ...
Jefferson Cunha Folquitto, Sérgio Barbosa de Barros, Jony Arrais Pinto Junior, Cássio M.C. Bottino   +3 more
doaj   +1 more source

Risperidone-related bilateral cystoid macular edema: a case report

Journal of Medical Case Reports, 2019
Background A report of the second known case of bilateral cystoid macular edema in a patient taking risperidone. Case presentation We report a case of a 69-year-old African American woman using risperidone who presented with worsening visual acuity and ...
Anna Kozlova, Charles D. McCanna, Rony Gelman   +2 more
doaj   +1 more source

Association of HTR2A Polymorphisms with Risperidone Efficacy in Chinese Han Schizophrenia Patients

Psychiatry and Clinical Psychopharmacology, 2021
Objectives: The 5-HT2A receptor is one of the most important serotonin receptors, serving as a major target for risperidone. Rs6311 and rs6313 polymorphisms in the HTR2A gene have been reported to be associated with response to risperidone treatment ...
Yucai Yan, Qinghe Xing, Lin He, Jingyuan Zhao, Wenqiang Li, Donghong Cui, Yichen Liu, Liya Sun, Lu Shen, Ran Huo, Jie Jiang, Yuyu Xiong, Zhiyun Wei, Shengying Qin   +13 more
doaj   +1 more source